Would you add atezolizumab to carboplatin + etoposide for small cell/neuroendocrine prostate cancer?

This is an excellent question. While small cell lung cancer and small cell prostate cancer share common genomics (RB1, TP53 mutation or loss for example) and histology, they differ in many important ways including divergent evolution from AR positive disease in many patients with transformed disease...